Engipharm
Engipharm, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in Spain (ES) and operates extensively across Europe and Latin America. Founded in 2005, the company has achieved significant milestones, establishing itself as a leader in the development of innovative healthcare solutions. Engipharm specialises in the production of high-quality generic medications and advanced biopharmaceuticals, distinguished by their commitment to rigorous quality standards and cutting-edge research. Their unique approach to drug formulation and delivery systems sets them apart in a competitive market. With a strong market position, Engipharm has garnered recognition for its contributions to patient care and has received various industry accolades, reflecting its dedication to excellence and innovation in the pharmaceutical sector.
DitchCarbon Score
How does Engipharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Engipharm's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Engipharm's reported carbon emissions
Engipharm, headquartered in Spain (ES), currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. In the absence of concrete emissions data, it is important to note that Engipharm has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the industry increasingly prioritises sustainability and carbon neutrality, Engipharm's future commitments and actions will be crucial in aligning with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Engipharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
